Alex R. Thurman sold $1.6M of Glaukos (GKOS)

Executed Jul 16, disclosed Jul 21, 5 days later, against a two-business-day limit.

Value, as filed

$1.6M

10,000 sh × $160.00

Executed

Jul 16

the trade date, as filed

Disclosed

Jul 21

5 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Alex R. Thurman SVP & CHIEF FINANCIAL OFFICER profile →

Alex R. Thurman (SVP & CHIEF FINANCIAL OFFICER) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales, 1 filed past the two-business-day deadline), most often in Glaukos Corporation (GKOS). The largest single filing was $3.6M of GKOS (20,000 sh × $180.13, as filed), executed Aug 7.

The name

GKOS

Glaukos Corporation GKOS · Healthcare · 31 filings in 24 months ticker →

Healthcare · Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Alex R. Thurman in GKOS

GKOSSALE Glaukos Corporation $3.6M
20,000 sh × $180.13
Exec Aug 7
Filed Aug 11 · 5:31 PM ET GKOSSALE Glaukos Corporation $1.6M
10,000 sh × $155.00
Exec Jul 9
Filed Jul 13 · 8:04 PM ET GKOSSALE Glaukos Corporation $1.5M
10,000 sh × $150.00
Exec Jul 6
Filed Jul 8 · 9:13 PM ET GKOSSALE Glaukos Corporation $1.4M
10,000 sh × $140.00
Exec Apr 30
Filed May 4 · 5:30 PM ET GKOSSALE Glaukos Corporation $267K
2,511 sh × $106.46
Exec Mar 25
Filed Mar 27 · 5:30 PM ET GKOSSALE Glaukos Corporation $160K
1,521 sh × $105.24
Exec Mar 24
Filed Mar 25 · 5:30 PM ET GKOSSALE Glaukos Corporation $113K
1,059 sh × $106.56
Exec Mar 25 2025
Filed Mar 27 2025 · 5:30 PM ET